Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges

  1. Abdullahi, I.N.
  2. Emeribe, A.U.
  3. Adekola, H.A.
  4. Abubakar, S.D.
  5. Dangana, A.
  6. Shuwa, H.A.
  7. Nwoba, S.T.
  8. Mustapha, J.O.
  9. Haruna, M.T.
  10. Olowookere, K.A.
  11. Animasaun, O.S.
  12. Ugwu, C.E.
  13. Onoja, S.O.
  14. Gadama, A.S.
  15. Mohammed, M.
  16. Daneji, I.M.
  17. Amadu, D.O.
  18. Ghamba, P.E.
  19. Onukegbe, N.B.
  20. Shehu, M.S.
  21. Isomah, C.
  22. Babayo, A.
  23. Ahmad, A.E.-F.
Aldizkaria:
Human Vaccines and Immunotherapeutics

ISSN: 2164-554X 2164-5515

Argitalpen urtea: 2021

Alea: 17

Zenbakia: 3

Orrialdeak: 620-637

Mota: Berrikuspena

DOI: 10.1080/21645515.2020.1812313 GOOGLE SCHOLAR lock_openSarbide irekia editor
Gordailu instituzionala: lock_openSarbide irekia Editor